Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
3.510
+0.050 (1.45%)
At close: Mar 9, 2026, 4:00 PM EDT
3.470
-0.040 (-1.14%)
After-hours: Mar 9, 2026, 5:42 PM EDT
Recursion Pharmaceuticals Market Cap
Recursion Pharmaceuticals has a market cap or net worth of $1.85 billion as of March 9, 2026. Its market cap has decreased by -54.58% in one year.
Market Cap
1.85B
Enterprise Value
1.19B
1-Year Change
-54.58%
Ranking
Category
Stock Price
$3.51
Market Cap Chart
Since April 16, 2021, Recursion Pharmaceuticals's market cap has decreased from $5.08B to $1.85B, a decrease of -63.47%. That is a compound annual growth rate of -18.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.83B | -14.14% |
| Dec 31, 2025 | 2.13B | -20.16% |
| Dec 31, 2024 | 2.67B | 24.83% |
| Dec 29, 2023 | 2.14B | 46.15% |
| Dec 30, 2022 | 1.46B | -49.51% |
| Dec 31, 2021 | 2.89B | -42.96% |
| Apr 16, 2021 | 5.08B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Syndax Pharmaceuticals | 1.95B |
| Aurinia Pharmaceuticals | 1.90B |
| Tyra Biosciences | 1.89B |
| Veradermics | 1.81B |
| Palvella Therapeutics | 1.81B |
| Zymeworks | 1.78B |
| Relay Therapeutics | 1.77B |
| Definium Therapeutics | 1.76B |